提供者与系统性红斑狼疮青少年对疾病活动的认知差异：一项队列研究。
Discordant Perception of Disease Activity Between Providers and Adolescents with Systemic Lupus Erythematosus: A Cohort Study.
机构信息
Department of Pediatrics, Donald and Barbara Zucker School of Medicine at Hofstra-Northwell, Hempstead, NY; Division of Pediatric Rheumatology, Cohen Children's Medical Center of NY, New Hyde Park, NY.
Department of Psychology, School of Social and Behavioral Sciences, Mercy University, Dobbs Ferry, NY.
出版信息
J Pediatr. 2024 Nov;274:114216. doi: 10.1016/j.jpeds.2024.114216. Epub 2024 Jul 27.
Abstract
Discordance in perception of disease activity between adolescent patients with lupus and their providers may influence disease outcomes. We found that patients endorsed higher perceptions of disease activity than providers. Discordance was present at all levels of disease activity, particularly in patients with high activity, nephritis, and/or taking corticosteroids or mycophenolate mofetil.
摘要
青少年狼疮患者及其提供者对疾病活动的感知不一致可能会影响疾病结局。我们发现，患者对疾病活动的感知高于提供者。在疾病活动的各个水平都存在不一致，特别是在疾病活动高、肾炎和/或服用皮质类固醇或吗替麦考酚酯的患者中。
相似文献
1
Discordant Perception of Disease Activity Between Providers and Adolescents with Systemic Lupus Erythematosus: A Cohort Study.提供者与系统性红斑狼疮青少年对疾病活动的认知差异：一项队列研究。
J Pediatr. 2024 Nov;274:114216. doi: 10.1016/j.jpeds.2024.114216. Epub 2024 Jul 27.
2
Juvenile systemic lupus erythematosus: a single-center experience from southern Turkey.幼年特发性关节炎：来自土耳其南部的单中心经验。
Clin Rheumatol. 2019 May;38(5):1459-1468. doi: 10.1007/s10067-019-04433-4. Epub 2019 Jan 16.
3
Mycophenolic acid exposure and complement fraction C3 influence inosine 5'-monophosphate dehydrogenase activity in systemic lupus erythematosus.霉酚酸暴露及补体C3对系统性红斑狼疮中肌苷5'-单磷酸脱氢酶活性的影响。
Ann Clin Biochem. 2017 Jul;54(4):490-494. doi: 10.1177/0004563216667753. Epub 2016 Aug 17.
4
Treatment of pulmonary hemorrhage in childhood systemic lupus erythematosus with mycophenolate mofetil.霉酚酸酯治疗儿童系统性红斑狼疮合并肺出血
South Med J. 2003 Jul;96(7):705-7. doi: 10.1097/01.SMJ.0000054424.20202.7D.
5
Outcomes following mycophenolate mofetil versus cyclophosphamide induction treatment for proliferative juvenile-onset lupus nephritis.霉酚酸酯与环磷酰胺诱导治疗增生性青少年狼疮性肾炎的结果。
Lupus. 2019 Apr;28(5):613-620. doi: 10.1177/0961203319836712. Epub 2019 Mar 14.
6
Nonrenal disease activity following mycophenolate mofetil or intravenous cyclophosphamide as induction treatment for lupus nephritis: findings in a multicenter, prospective, randomized, open-label, parallel-group clinical trial.霉酚酸酯或静脉注射环磷酰胺作为狼疮性肾炎诱导治疗后的非肾疾病活动：一项多中心、前瞻性、随机、开放标签、平行组临床试验的结果
Arthritis Rheum. 2010 Jan;62(1):211-21. doi: 10.1002/art.25052.
7
Mycophenolate mofetil treatment of severe renal disease in pediatric onset systemic lupus erythematosus.霉酚酸酯治疗儿童起病的系统性红斑狼疮严重肾脏疾病
J Rheumatol. 2001 Sep;28(9):2103-8.
8
Association of systemic lupus erythematosus standard of care immunosuppressants with glucocorticoid use and disease outcomes: a multicentre cohort study.系统性红斑狼疮标准治疗的免疫抑制剂与糖皮质激素的使用及疾病结局的相关性：一项多中心队列研究。
Adv Rheumatol. 2024 May 8;64(1):38. doi: 10.1186/s42358-024-00366-y.
9
Mycophenolate Mofetil in Nonrenal Manifestations of Systemic Lupus Erythematosus: An Observational Cohort Study.霉酚酸酯治疗系统性红斑狼疮的非肾脏表现：一项观察性队列研究
J Rheumatol. 2016 Mar;43(3):552-8. doi: 10.3899/jrheum.150779. Epub 2016 Jan 15.
10
Mycophenolate mofetil as maintenance therapy for childhood-onset systemic lupus erythematosus patients with severe lupus nephritis.霉酚酸酯作为儿童期起病的重症狼疮性肾炎系统性红斑狼疮患者的维持治疗药物。
Mod Rheumatol. 2015 Mar;25(2):210-4. doi: 10.3109/14397595.2014.950810. Epub 2014 Aug 27.
本文引用的文献
1
Medication decision-making and adherence in lupus: patient-physician discordance and the impact of previous 'adverse medical experiences'.狼疮患者的药物决策和依从性：医患分歧以及先前“不良医疗经历”的影响。
Rheumatology (Oxford). 2022 Apr 11;61(4):1417-1429. doi: 10.1093/rheumatology/keab534.
2
Understanding patient-provider discordance in adolescents with lupus: The role of pain and antidepressant medication use.了解狼疮青少年患者与医疗服务提供者之间的不一致：疼痛和抗抑郁药物使用的作用。
Health Psychol Open. 2020 Dec 8;7(2):2055102920977714. doi: 10.1177/2055102920977714. eCollection 2020 Jul-Dec.
3
Determinants of Discordance Between Criteria for Inactive Disease and Low Disease Activity in Juvenile Idiopathic Arthritis.青少年特发性关节炎中无疾病活动与低疾病活动标准之间不一致的决定因素。
Arthritis Care Res (Hoboken). 2021 Dec;73(12):1722-1729. doi: 10.1002/acr.24415. Epub 2021 Oct 11.
4
Patient and physician discordance of global disease assessment in juvenile dermatomyositis: findings from the Childhood Arthritis & Rheumatology Research Alliance Legacy Registry.患者和医生对青少年皮肌炎全球疾病评估的不一致：来自儿童关节炎与风湿病研究联盟遗产登记处的发现。
Pediatr Rheumatol Online J. 2020 Jan 15;18(1):5. doi: 10.1186/s12969-020-0402-x.
5
Using Clinical Characteristics and Patient-Reported Outcome Measures to Categorize Systemic Lupus Erythematosus Subtypes.使用临床特征和患者报告的结局测量来分类系统性红斑狼疮亚型。
Arthritis Care Res (Hoboken). 2021 Mar;73(3):386-393. doi: 10.1002/acr.24135.
6
Discordance of patient and physician health status concerns in systemic lupus erythematosus.系统性红斑狼疮患者与医生健康关注点的不一致。
Lupus. 2018 Mar;27(3):501-506. doi: 10.1177/0961203317722412. Epub 2017 Aug 1.
7
Responsiveness of the 36-item Short Form Health Survey and the Lupus Quality of Life questionnaire in SLE.36项简明健康调查问卷及狼疮生活质量问卷在系统性红斑狼疮中的反应性
Rheumatology (Oxford). 2015 May;54(5):940-9. doi: 10.1093/rheumatology/keu410. Epub 2014 Oct 30.
8
Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus.系统性红斑狼疮国际协作临床分类标准的推导与验证
Arthritis Rheum. 2012 Aug;64(8):2677-86. doi: 10.1002/art.34473.
9
Prospective validation of the provisional criteria for the evaluation of response to therapy in childhood-onset systemic lupus erythematosus.儿童起病系统性红斑狼疮治疗反应评估临时性标准的前瞻性验证。
Arthritis Care Res (Hoboken). 2010 Mar;62(3):335-44. doi: 10.1002/acr.20103.
10
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.《流行病学观察性研究报告强化（STROBE）声明》：观察性研究报告指南
J Clin Epidemiol. 2008 Apr;61(4):344-9. doi: 10.1016/j.jclinepi.2007.11.008.
Zotero 插件